BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Paka L, Smith DE, Jung D, McCormack S, Zhou P, Duan B, Li JS, Shi J, Hao YJ, Jiang K, Yamin M, Goldberg ID, Narayan P. Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease. World J Gastroenterol 2017; 23(23): 4181-4190 [PMID: 28694658 DOI: 10.3748/wjg.v23.i23.4181]
URL: https://www.wjgnet.com/1007-9327/full/v23/i23/4181.htm
Number Citing Articles
1
Benjamin Soret, Jurek Hense, Simon Lüdtke, Insa Thale, Albrecht Schwab, Martina Düfer. Pancreatic KCa3.1 channels in health and diseaseBiological Chemistry 2023; 404(4): 339 doi: 10.1515/hsz-2022-0232
2
Bo Chen, Donghong Sun, Xiuni Qin, Xing-Hua Gao. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysisInvestigational New Drugs 2021; 39(4): 928 doi: 10.1007/s10637-021-01072-y
3
Kimberly Liao, Anthony J. Pellicano, Kai Jiang, Natalia Prakash, Jingsong Li, Shraddha Bhutkar, Zhijian Hu, Quaisar Ali, Itzhak D. Goldberg, Prakash Narayan. Glycerol-3-phosphate Acyltransferase1 Is a Model-Agnostic Node in Nonalcoholic Fatty Liver Disease: Implications for Drug Development and Precision MedicineACS Omega 2020; 5(29): 18465 doi: 10.1021/acsomega.0c02350
4
Anne Hwang, Christopher Shi, Edward Zhu, Farha Naaz, Ping Zhou, Zainab Rasheed, Michelle Liu, Lindsey S. Jung, Bin Duan, Jingsong Li, Kai Jiang, Latha Paka, Satishkumar V. Gadhiya, Dibyendu Dana, Quaisar Ali, Michael A. Yamin, Itzhak D. Goldberg, Prakash Narayan, Mahesh Narayan. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASHPLOS ONE 2018; 13(6): e0198937 doi: 10.1371/journal.pone.0198937
5
Aristote B. Buya, Bernard Ucakar, Ana Beloqui, Patrick B. Memvanga, Véronique Préat. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDSs) for senicapocInternational Journal of Pharmaceutics 2020; 580: 119180 doi: 10.1016/j.ijpharm.2020.119180
6
Tyler L. Bissoondial, Yiguang Han, Stephanie Mullan, Amrit K. Pabla, Kiera Spahn, Steven Shi, Lana Zheng, Ping Zhou, Kai Jiang, Natalia Prakash, Shraddha Bhutkar, Quaisar Ali, Jingsong Li, Zhijian Hu, Anthony J. Pellicano, Itzhak D. Goldberg, Prakash Narayan. Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic SteatohepatitisDiagnostics 2020; 10(10): 784 doi: 10.3390/diagnostics10100784
7
Xingyue Chen, Li Zhang, Liming Zheng, Biguang Tuo. Role of Ca2+ channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (Review)International Journal of Molecular Medicine 2022; 50(3) doi: 10.3892/ijmm.2022.5169
8
Katy M. Roach, Peter Bradding. Ca2+ signalling in fibroblasts and the therapeutic potential of KCa3.1 channel blockers in fibrotic diseasesBritish Journal of Pharmacology 2020; 177(5): 1003 doi: 10.1111/bph.14939
9
Peter Bradding, Gunnar Pejler. The controversial role of mast cells in fibrosisImmunological Reviews 2018; 282(1): 198 doi: 10.1111/imr.12626
10
Tianying Duan, Onur Cil, Jay R. Thiagarajah, Alan S. Verkman. Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrheaJCI Insight 2019; 4(4) doi: 10.1172/jci.insight.126444
11
Zoltán Pethő, Karolina Najder, Etmar Bulk, Albrecht Schwab. Mechanosensitive ion channels push cancer progressionCell Calcium 2019; 80: 79 doi: 10.1016/j.ceca.2019.03.007
12
Shinkyu Choi, Ji Aee Kim, Haiyan Li, Seong-Eun Jo, Huisu Lee, Tae Hun Kim, Minje Kim, Seong-Jin Kim, Suk Hyo Suh. Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver diseaseBiomedicine & Pharmacotherapy 2021; 144: 112372 doi: 10.1016/j.biopha.2021.112372